Pharma.AI Day 2025: Register now! Insilico Medicine to unveil gen-AI platform quarterly updates on April 24
Business Announcement
Cambridge, MA, April 18— Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, is proud to announce Pharma.AI Day 2025, the brand-new quarterly update series for Pharma.AI, scheduled on April 24, 10:00-11:00 AM EST. Register here to join Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, and get a deep dive into a series of AI breakthroughs and new product demos.
The University of Texas at Arlington, with 23 patents granted in 2024, helped propel The University of Texas System to No. 3 in the National Academy of Inventors’ prestigious top 100 ranking of U.S. universities awarded utility patents. The UT System’s 14 institutions are collectively ranked as a single entity in the National Academy of Inventors’ (NAI) annual report. UT Arlington’s 23 patents is a 15% jump from the previous year.
The World Cocoa Foundation (WCF) and the Alliance of Bioversity International and CIAT have assessed the most commonly used maps for environmental compliance.
The 6G Test Center at the University of Oulu Finland has commenced testing services for corporate clients. The first client is the Finnish glass processing factory Tambest which also has export operations.
In dual-use products, innovation can arise from the intersection and combination of traditional products and features that meet future needs. The 6G Test Center already enables simulation of wireless communication scenarios of the 2030s. With the first client, various bulletproof glasses with signal interference protection were tested. The focus of the 6G Test Center's research is on dual-use technologies utilized in both civilian and defense sectors. The center is part of NATO's DIANA research network.